The Pharmaceutical Press

Investment will accelerate scale up of Nano’s platform to expand vaccine access and alternate delivery.   AUSTIN, Texas and DUBAI, UAE (Arab Newswire)   --   Nano Cures Inc. (“ Nano ”), a clinical stage biotechnology and infectious disease immunity platform company, today announced a $90M pre-IPO funding round. The investment will be led by a $20M commitment from Opulence Capital Management, a Dubai based private investment fund, with existing and new investors participating. The investment will accelerate the global scale up of Nano’s Cures Platform for Covid-19 variants, including vaccines and persistent immunity delivery. Nano’s novel self- administered technology moves delivery beyond syringes and shots, to an array of nasal, dermal, ophthalmic, sub-lingual, and oral options. Nano will open up its Cures Platform to other pharmaceutical companies and their vaccines, providing dynamic new ways to con...

Freedom Fries, LLC, a service-disabled veteran owned small business announces partnership with Medsential, LLC for distribution of their COVID-19 rapid test with results in 15 minutes.     Las Vegas, NV - ( EMAILWIRE ) -   Freedom Fries, LLC., a subsidiary of Terraformance, LLC., is proud to announce a distributor partnership with Medsential, LLC. to distribute their FDA Approved FaStep COVID19 IgM/IgG Rapid Tests for immediate delivery at Point-of-Care locations.   What does Point-of-Care (POC) mean? This authorization means finger stick blood samples can now be tested in POC setting like Doctor Offices, Hospitals, Urgent Care Centers, Emergency Rooms, Pharmacies and Dental practices rather than having blood drawn to be tested in a central lab. This is particularly useful to organizations that need to test their patients and/or personnel for COVID infections prior to work or activity. This test is not designed or approved for at home use.   This test is also s...

    Miami, FL – January 7, 2021 – EMAILWIRE – Bonne Santé Group, Inc., or BSG, an emerging growth Health & Wellness company in the nutraceutical sector, announced today that it has engaged Alan Bergman, CPA as Chief Financial Officer effective January 1, 2021.  The announcement was made by A.J. Cervantes, Jr., Bonne Santé Group's Executive Chairman. "As Bonne Santé Group is on a path to public status in 2021, Alan's deep public company experience is invaluable in the execution of our strategic initiatives," stated Mr. Cervantes. "In addition to his accounting expertise, his finance knowledge and experience will not only serve to support but help drive our proactive acquisition strategies." Mr. Bergman brings to BSG a successful financial history in both the public and private sectors, having commenced his career at Deloitte & Touche LLP in 2000.  His career path includes Senior Auditor at Weinberg & Company, P.A.; Audit Manager at Mallah Furma...

Stay calm with Calmerry: online therapy platform is offering tools to licensed professionals , so they can help clients overcom e stress and anxiety through individual, couples and family therapy   Washington DC, ( EMAILWIRE.COM ) -- C almerry , an online therapy platform, proposes affordable solutions with effective online therapy tools. After rolling in the beta-version for several months and collecting positive feedback, Calmerry is now up  and running in full. Calmerry is a meaningful and human-oriented online therapy platform. It provides best matching with licensed professionals and continuity of support across an individual’s therapy journey. The platform provides the assistance of human-operated support available 24/7 to help and give accurate answers to any questions.   Calmerry ensures affordability with different subscription plans to choose from, starting at just $ 53 per week , and flexibility by covering a wide range of areas and granting an oppo...

The major driving factors for process and preparative chromatography market include increasing demand for insulin and other biopharmaceutical products Saudi Arabia -- (BLOGGERS NETWORK ) --The major driving factors for process and preparative chromatography market include increasing demand for insulin and other biopharmaceutical products, high demand for omega-3 fatty acids, and rising awareness about advancements in process and preparative chromatography. Emerging economies such as India, China, and Brazil provide opportunity for the players operating in the process and preparative market. However, high cost of instrument and availability alternative techniques for purification and separation of pharmaceutical products are the major restraining factors for this market. The process and preparative chromatography market size is expected to reach USD 8.60 billion by 2023 from the estimated USD 6.27 billion in 2018, at a CAGR of 6.5%. The  preparative and process chromatography m...

European Mammography Workstations Market by Modality (Multimodal, Standalone), Application (Diagnosis, Advanced Imaging, Clinical Review), End User (Hospital, Breast Care Centers, Academia), Country (Germany, UK, France, Italy, Spain) - Forecast to 2024 Saudi Arabia --(BLOGGERS NETWORK )-- [115 Pages Report] The  European Mammography Workstations Market  is estimated to grow at a CAGR of 5.5% to reach USD 14 million by 2024 from USD 10 million in 2018. This study involved four major activities in estimating the current size of the European mammography workstations market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and the parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Primary Research: Extensive primary research was conduc...

Healthcare Chatbots Market by Component (Software, Service), Deployment Model (Cloud, On-Premise), Application (Symptom Check, Medical Assistance, Appointment Booking), End User (Patient, Healthcare Providers, Insurance Companies) - Global Forecast to 202 (BLOGGERS NETWORK) Chatbots are adopted among the developed countries such as North and Europe, and is yet to witness widespread adoption in emerging countries, where doctors and other healthcare providers are still reluctant to adopt advanced healthcare solutions. Data privacy concerns and a lack of sufficiently skilled personnel to develop healthcare chatbots also serve to affect market growth to a certain extent. Need for virtual assistance, and rising Internet connectivity and adoption of smart devices are factors driving the growth of healthcare chatbots market. By component, the software segment is estimated to lead the market in 2018. Based on component, the  healthcare chatbots market  is segmented into software ...